Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. - Wikidata - wikimedia - TriplyDB

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

http://www.wikidata.org/entity/Q33926334

about

Pharmacogenomics discovery and implementation in genome-wide association studies era Genotype-based ancestral background consistently predicts efficacy and side effects across treatments in CATIE and STAR*D ANKS1B Gene Product AIDA-1 Controls Hippocampal Synaptic Transmission by Regulating GluN2B Subunit Localization Genome-wide association study of paliperidone efficacy Genome-wide association analysis of age-at-onset in Alzheimer's disease Pharmacogenetics of antipsychotics.Biomarkers in development of psychotropic drugs.SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study Replication of SULT4A1-1 as a pharmacogenetic marker of olanzapine response and evidence of lower weight gain in the high response group.Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.Genome-wide association studies in pharmacogenomics: successes and lessons.Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction Personalized medicine in psychiatry: problems and promises.Horizons of psychiatric genetics and epigenetics: where are we and where are we heading?Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.The promise and reality of pharmacogenetics in psychiatry Analysis of efficacy and side effects in CATIE demonstrates drug response subgroups and potential for personalized medicine How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?iCLIP identifies novel roles for SAFB1 in regulating RNA processing and neuronal function Genome-wide association study of antipsychotic-induced QTc interval prolongation.Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations.The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood.Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.Genome-Wide Meta-Analysis of Longitudinal Alcohol Consumption Across Youth and Early Adulthood.Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration.Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Pharmacogenetics in psychiatry: translating research into clinical practice.Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.Integrative genomics strategies to elucidate the complexity of drug response.Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.Pharmacogenomics can improve antipsychotic treatment in schizophrenia.

P2860

Q27001573-3ECCACB7-77AB-40F8-A165-EE5F521C05E1 Q28486019-2853434C-EB20-403F-B5E9-31C2AA1C9B79 Q28511930-E87CAEEB-F1D0-4078-A1F6-1CA207C9919D Q28587963-19BDA38A-4AD3-40E4-9448-1A98D09709DA Q29417033-1D6E8AEB-4A6C-4404-9BB2-CCD284343505 Q33836837-CFEAAC21-128F-4B3D-BBC7-DBF737CCC711 Q33993209-E4EBF109-7A1A-41D5-AF18-CFEEE6BF6069 Q34078643-3B74226E-F64D-432F-9279-41D9B76E0252 Q34155219-63AFEE2E-6E1E-4C6C-AA36-04E9877D4758 Q34229109-D617D005-9A07-44CF-B2C1-C31C8AAEF89A Q34415006-83BE20A0-72A8-4332-B5F8-58A93201881C Q34644655-3A6B871B-6A92-4852-8705-65C3975F5561 Q34676533-1AC7C971-AADF-4241-BD9A-E335CACA9770 Q34726454-AB5C6913-1FF7-453F-89E8-A2D57311EA8D Q35177686-61BD2DB6-E97B-4290-BF45-38B899565746 Q35200854-9475A02B-4112-4F58-BFA4-E81F69D33228 Q35226451-C5FCCD33-1E7D-4331-87ED-73A6AF021EFC Q35375788-DEBE3906-D6BB-496F-AFDA-527847A86A18 Q35610726-0C061C0A-91D7-432E-9660-C20A1CA23D14 Q35875612-C0F20E50-0B23-4A6C-9FEE-627794540BF1 Q36073692-11A3F68B-86A5-4C26-9685-7DC1109B0372 Q36135959-A098D508-2C55-4A6D-B1C9-7FE27FA25917 Q36189837-EC7CA002-DB2F-4149-988B-1B21BEE947AD Q36447406-13DABA75-FA1E-44FD-9CB6-6B79B42AFBC9 Q36448838-DBDC3177-4FB4-4B36-B0D0-BB5723BC3D4A Q36456196-8263A289-DEA5-42FE-BCA0-67EA78394662 Q36604310-B210A2E5-6509-44A4-A5EC-39291A445748 Q36702588-E3527EEF-CF31-47A5-A331-80BA9ADE132D Q36915452-40684DAF-B5C1-4866-B939-AA7CF34CBD0D Q37347570-C64074C6-09BB-4A6E-B48C-4EF6E44BCDD6 Q37353278-4A5AC2CD-EAC8-4041-BE11-2118CF784091 Q37452489-6D1A258C-5297-4565-838D-6F512DB0667F Q37581282-97D7D4CA-8516-4E58-B8FD-2B20A93B1622 Q37602618-D5EFB1A0-51E6-46A0-AE43-C73DB71CB3CF Q37952823-9A675E84-3BD0-4BB8-8DF2-57E30157D7E1 Q37956206-01F308A6-3C24-4D1B-8E7C-1FB9EE771A87 Q37960512-6BEAAC27-1207-42D3-A055-AE5E79177929 Q37961088-49C56D79-D290-48B1-A634-B96C67ED4EE8 Q38061501-8C7813B8-F3E3-495A-9BBF-4AC1FB3C8BAE Q38100731-53574C32-BF32-468F-BDE1-539B50B8FDD2

P2860

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

http://www.wikidata.org/entity/Q33926334

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

@ast

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

@en

type

label

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

@ast

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

@en

prefLabel

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

@ast

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

@en

P1433

Q33926334-102C2AD8-14F1-4FAA-8F4D-0A761377D308

P1476

Q33926334-3E483ABA-8169-49B9-A08E-9101EFF07A7B

P2093

Q33926334-51C60ECF-DD6B-4882-BB6F-047302DA2AD0

Q33926334-5C726258-EE32-41DD-9269-F23D07FEBA6A

Q33926334-ADD51F85-E423-4712-9427-6617AE8502B7

Q33926334-B3AC5176-6D40-42EB-BAD1-A387C30075D1

Q33926334-DDC7798F-D511-4A93-A537-ABDF4CE09CD7

Q33926334-F0B5B4A0-6E3B-4455-BE88-29CF776301DC

P2860

Q33926334-012DB7F2-13C5-46B0-A075-86C2490DD9EC

Q33926334-01DC32EA-8270-4C8F-8D4D-BF88A6019F24

Q33926334-062BBEE6-424E-4E45-AECE-5F8421BA6D6C

Q33926334-07B5C43D-985E-4E58-94B2-96C3B0E81FB9

Q33926334-0B4D407D-A3E7-4E78-B9F7-49F743EF27FD

Q33926334-0F96902D-F257-46BA-9EC4-D76FF679A3EF

Q33926334-11737A1A-2A75-4FB7-86B1-6357E991C3CC

Q33926334-118A1056-5ECC-4443-90B2-B90BC91938D7

Q33926334-1205478E-DF8F-46AD-89AE-9482001034EB

Q33926334-14506288-F582-44B4-973A-6C4EE511C8F4

P2888

Q33926334-518CBB66-BC45-4BAB-BE4F-CEE8D8486D9F

P304

Q33926334-4FD124DF-751C-45F6-9CAD-55FAF5B9CD5D

P31

Q33926334-2782A938-CFBA-49AA-A7C9-D6BE0FEEE1A1

P356

Q33926334-2B314018-463C-4F1C-8E07-8E152513242D

P407

Q33926334-1D0B695B-B054-4681-A5DC-270611CEB70E

P433

Q33926334-3EE420B8-9568-4ED6-80E3-357EFB5D9ABF

P478

Q33926334-5724938B-EF0F-4158-B212-CE8FDB5BF475

P50

Q33926334-94CF82FD-8E37-48CC-BABC-E5098474AF9B

Q33926334-C744AF9A-A0A3-49A3-AAC3-91313A4F0B20

Q33926334-C8A96942-D283-43F0-A89E-4A15E59B91AC

P577

Q33926334-A8C23BD1-5271-4E6E-A6D6-D009FDCE8567

P5875

Q33926334-36940599-BD0F-4075-BFCD-A57B9223A68C

P698

Q33926334-7A54BF88-3492-4B53-9258-BDD03A128A0F

P921

Q33926334-DE728439-D96A-47CF-BDC1-62789B67C152

P932

Q33926334-B3C762EB-38D1-4D80-A150-FDB5FEC9883F

P356

P1433

Molecular Psychiatry

P1476

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics

@en

P2093

D E Adkins

http://www.w3.org/2001/XMLSchema#string

D O Perkins

http://www.w3.org/2001/XMLSchema#string

E J C G van den Oord

http://www.w3.org/2001/XMLSchema#string

J A Lieberman

http://www.w3.org/2001/XMLSchema#string

P F Sullivan

http://www.w3.org/2001/XMLSchema#string

V I Vladimirov

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of the prevalence of schizophrenia.

Population structure and eigenanalysis

A note on exact tests of Hardy-Weinberg equilibrium

The UCSC Genome Browser Database: update 2006

Complement factor H polymorphism in age-related macular degeneration

Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

PLINK: a tool set for whole-genome association and population-based linkage analyses

A haplotype map of the human genome

P2888

P304

76-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MP.2009.89

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Joseph L. McClay

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26781066

http://www.w3.org/2001/XMLSchema#string

P698

19721433

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

2888895

http://www.w3.org/2001/XMLSchema#string